Regeneron announces positive phase 2 data evaluating fel d 1 antibody cocktail in cat-allergic patients with mild asthma

Tarrytown, n.y., feb. 27, 2021 /prnewswire/ -- single administration of novel antibody cocktail controlled patients' allergic response to cat allergen, preventing early asthma reactions for the duration of the 3-month trial patients experienced significant improvements in lung function...
REGN Ratings Summary
REGN Quant Ranking